Form 4 for VVOS Vivos Therapeutics, Inc.
Accepted 2023-06-20 00:00:00 ET · period of report 2023-06-15 · accession 0001493152-23-021751 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-06-20 | 2023-06-15+ | VVOS | Huntsman Ronald Kirk | CEO, Dir | P - Purchase | $0.5366 | +15.0K | 57.5K | +35% | +$8,060 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-16 | P | A | 5,000 | $0.53 | 72,521 | D | — | — | |
| 2 | Common | Common Stock | 2023-06-16 | P | A | 10,000 | $0.54 | 67,521 | D | — | — | |
| 3 | Common | Common Stock | 2023-06-15 | P | A | 21 | $0.5 | 57,521 | D | — | — |